MindMaze is a leading global brand in brain technology with a mission to accelerate humanity's ability to recover, learn, and adapt. Founded in 2012, MindMaze has made significant strides in the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence. Their Healthcare division focuses on creating the universal solution for neurorehabilitation through FDA and CE cleared digital therapeutics.

These innovative solutions have greatly enhanced the recovery potential of patients with neurological diseases. In addition to their Healthcare division, MindMaze has an enterprising R&D division called MindMaze Labs. This division harnesses the power of the brain to develop cutting-edge neurotechnology, empowering the next generation of human-machine interfaces.

Through their groundbreaking work, MindMaze is revolutionizing care for debilitating neurological diseases and improving every aspect of life. With their headquarters in Lausanne, Switzerland, MindMaze has expanded its reach globally, establishing offices in the US, UK, Germany, and China. The brand has achieved numerous milestones, including being recognized as the first Swiss unicorn, obtaining FDA and CE certifications, and filing multiple patents covering their technology innovations.

In summary, MindMaze is at the forefront of neurotechnology, developing game-changing solutions that unlock the true power of humanity's brain